Spinraza (nusinersen) is able to help slow lung function decline in people with spinal muscular atrophy (SMA), even if treatment is started when patients are already experiencing disease symptoms, a new study shows. The beneficial effects of the approved SMA therapy on lung function were generally more pronounced among children with the condition than adults, […] The post Spinraza shown to slow lung function decline in SMA patients with symptoms appeared first on SMA News Today .

Source: https://smanewstoday.com/news/spinraza-shown-slow-lung-function-decline-symptomic-sma-patients/ (Fri, 22 May 2026)

Ingested by the SMA platform's daily smanewstoday.com RSS pipeline. Cross-linked to our knowledge graph via the news auto-scoring cron.